Eloxx Pharmaceuticals
Presença
Eloxx Pharmaceuticals é uma empresa listada sob o símbolo ELOX (US).
Executivos
Veja o organograma con seus 7 executivos principais
Biografias mais buscadas da Eloxx Pharmaceuticals
- Sumit Aggarwal, President, Chief Executive Officer
- Tomer Kariv, Chairman of the Board
- Alan Walts, Director
Criar um alerta
para seguir os movimentos de executivos da Eloxx Pharmaceuticals.
Farmacêutica
Eloxx Pharmaceuticals possui 1.861 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Eloxx Pharmaceuticals
- Eloxx Pharmaceuticals Announces Changes to Board of Directors | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Announces Therapeutic Development Award from Cystic Fibrosis Foundation | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports Fourth Quarter 2021 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Announces New Development Program for ELX-02 for the Treatment of Alport Syndrome | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Business Update on November 5, 2020 | Eloxx Pharmaceuticals, Inc.
- Globally Renowned Cystic Fibrosis Expert, Dr. Eitan Kerem, Joins Eloxx Pharmaceuticals as a Senior Consultant | Eloxx Pharmaceuticals, Inc.
- Eloxx Announces Two Preclinical Abstracts Accepted for Presentation at the 2020 North American Cystic Fibrosis Virtual Conference in October | Eloxx Pharmaceuticals, Inc.
- Enrollment in the U.S. Phase 2 Clinical Trial in Cystic Fibrosis Has Resumed After Being Paused in Response to the COVID-19 Pandemic | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- View more press releases Close
Redes sociais sobre Eloxx Pharmaceuticals
- Eloxx Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Eloxx Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Lindsay Androski 
Ligue para a Eloxx Pharmaceuticals em +1 781...
